1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6BF1302F74785F4A500258C59001FD726
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-improving-medical-affairs-booth-impact-oncology-congresses-performance-measurement-msl-content?opendocument
18
19opendocument
2018.97.9.172
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Improving Medical Affairs Booth Impact at Oncology Congresses: Performance Measurement and Innovative MSL Content

ID: 5868


Features:

7 Info Graphics

11 Data Graphics

150+ Metrics


Pages/Slides: 25


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Improving Medical Affairs Booth Impact at Oncology Congresses: Performance Measurement and Innovative MSL Content”

STUDY OVERVIEW

Oncology congresses bring together a diverse group of key stakeholders, including oncologists, researchers, and other healthcare professionals (HCPs), to exchange insights on emerging therapies and clinical advancements. To maximize booth impact, biopharma companies are refining performance measurement strategies and implementing innovative MSL-led content to enhance scientific engagement across this broad audience.

This benchmarking study by Best Practices, LLC explores how companies evaluate booth effectiveness at oncology congresses, including key performance metrics and assessment methodologies. Additionally, it highlights innovative MSL content strategies that enhance scientific exchange and engagement, ensuring that booth interactions drive meaningful discussions and knowledge transfer.

KEY TOPICS

  • Metrics and KPIs for Measuring Medical Booth Success at Oncology Events
  • Best Practices and Common Pitfalls in Oncology Booth Content Display
  • Innovative MSL Content Strategies to Support Scientific Exchange at Oncology Congresses

KEY METRICS

  • Oncology booth strategies that effectively draw in congress attendees
  • Booth content effectiveness metrics used in oncology
  • Most valuable vs. most used metrics for oncology booth success measurement
  • Channels for oncology content distribution to congress attendees
  • Permissions for distributing oncology booth materials via email
  • Oncology-specific MSL content sharing methods and field usage
  • Innovative materials used by MSLs in the field and sharing methods (proactive vs. reactive)
  • Adoption and sharing of innovative MSL materials in oncology
  • Oncology booth insights shared by MSLs
  • Use of oncology-focused poster books by MSLs in the field
  • MSL-hosted oncology receptions and attendee eligibility

SAMPLE KEY FINDINGS

  • Field Medical Team Support of Oncology Booth: MSLs play a special role in supporting the dissemination of medical information at oncology booths. Disease state information (via slide decks, 2-D videos and 3-D videos) are most often, and proactively, shared by MSLs at congresses.

METHODOLOGY

Practices, LLC collaborated with
20 leaders in Medical Communications and Scientific Publications from 17 biopharma companies for this comprehensive study. While the overall research provides broad industry insights, the oncology-specific analysis is based on data from 7 biopharma companies actively involved in oncology congresses. The research employed a quantitative survey as the primary method of data collection, enriched with qualitative insights to highlight industry-leading strategies and emerging trends.

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Biopharmaceutical; Health Care


Companies Profiled:
Amgen; Astellas; Bayer; Chiesi Global Rare Diseases; EMD Serono; Ipsen; Incyte; Morphic Therapeutic; Novartis; OPEN Health; Protagonist Therapeutics; Purdue Pharma; Regeneron; Takeda Pharmaceuticals; Teva Pharmaceuticals; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.